Is Ambey Laboratories Ltd debt-free?

No, Ambey Laboratories Ltd is not debt-free with a debt-to-equity ratio of 0.53.

Home

Ambey Laboratories Ltd

Ambey Laboratories Ltd Financials

Ambey Laboratories Ltd Financial Statement

Ambey Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Ambey Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	120.47	104.82	84.60
Operating Expenses Annual	111.40	97.00	74.26
Operating Profit Annual	10.36	10.53	10.85
Interest Annual	2.41	2.06	3.05
Depreciation	2.52	2.96	2.97
Net Profit Annual	7.72	5.24	3.57
Tax Annual	-2.29	0.26	1.26

Particulars	Mar 2024
Total Revenue Annual	120.47
Operating Expenses Annual	111.40
Operating Profit Annual	10.36
Interest Annual	2.41
Depreciation	2.52
Net Profit Annual	7.72
Tax Annual	-2.29

Ambey Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.40	0.27	0.51
Cash Flow from Operations	-12.94	10.05	5.61
Cash Flow from Investing	-5.28	-3.69	-0.75
Cash Flow from Financing	14.48	-6.23	-5.08
Cash Flow at the End	-3.35	0.40	0.29

Particulars	Mar 2024
Cash Flow at the Beginning	0.40
Cash Flow from Operations	-12.94
Cash Flow from Investing	-5.28
Cash Flow from Financing	14.48
Cash Flow at the End	-3.35

Ambey Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	8.61	10.07	12.84
PBIT Margin (%)	6.52	7.25	9.33
PBT Margin (%)	3.83	3.79	6.28
Net PROFIT Margin (%)	6.41	5.00	4.22
Return On Networth / Equity (%)	38.46	29.52	31.54
Return On Networth /Employed (%)	18.59	22.12	20.89
Return On Assets (%)	16.28	14.70	11.14
Total Debt / Equity (X)	1.48	1.87	72.82
Asset Turnover Ratio (%)	2.54	2.94	2.64

Particulars	Mar 2024
PBDIT Margin (%)	8.61
PBIT Margin (%)	6.52
PBT Margin (%)	3.83
Net PROFIT Margin (%)	6.41
Return On Networth / Equity (%)	38.46
Return On Networth /Employed (%)	18.59
Return On Assets (%)	16.28
Total Debt / Equity (X)	1.48
Asset Turnover Ratio (%)	2.54

Ambey Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	23.98	25.22	25.09
Total Current Assets Annual	48.42	27.92	24.42
Non Current Assets Annual	30.99	26.06	31.51
Total Shareholders Funds Annual	31.51	19.14	19.07
Total Assets Annual	79.41	53.98	55.93

Particulars	Mar 2024
Fixed Assets Annual	23.98
Total Current Assets Annual	48.42
Non Current Assets Annual	30.99
Total Shareholders Funds Annual	31.51
Total Assets Annual	79.41

Ambey Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Ambey Laboratories Ltd Financials

As of Sep 5, 2025, Ambey Laboratories Ltd has a market capitalization of 100.29 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Ambey Laboratories Ltd is not with a debt-to-equity ratio of 0.53.

In FY 2024 , Ambey Laboratories Ltd recorded a total revenue of approximately 131.27 Cr marking a significant milestone in the company's financial performance.

Ambey Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.1% annually, respectively..

Ambey Laboratories Ltd's current PE ratio is 20.98.

Ambey Laboratories Ltd's ROCE averaged 13.8% from the FY ending March 2023 to 2025, with a median of 12.8%. It peaked at 21.3% in March 2023, reflecting strong capital efficiency over the period..

Ambey Laboratories Ltd's latest EBIT is Rs. 8.58 Cr, surpassing the average EBIT of Rs. 8.16 Cr over the 5 years..